(Q35030797)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12492704%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

review article

1 reference

title

HLA-G in transplantation: a relevant molecule for inhibition of graft rejection? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12492704%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12492704%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

4

Jean Dausset

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12492704%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

Philippe Moreau

3

1 reference

ORCID Public Data File 2021

Edgardo D. Carosella

series ordinal

5

object named as

Edgardo D Carosella

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12492704%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

Nathalie Rouas-Freiss

series ordinal

1

object named as

Nathalie Rouas-Freiss

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12492704%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

language of work or name

English

0 references

publication date

1 January 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12492704%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Transplantation

16 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12492704%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

volume

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12492704%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12492704%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

page(s)

11-16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12492704%20AND%20SRC:MED&resulttype=core&format=json

HLA-G gene polymorphism segregation within CEPH reference families

16 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.30103.X

Identification of HLA-G7 as a new splice variant of the HLA-G mRNA and expression of soluble HLA-G5, -G6, and -G7 transcripts in human transfected cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.30103.X

HLA-G and HLA-E: fundamental and Pathophysiological aspects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.30103.X

A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.30103.X

A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.30103.X

Inhibitory receptors sensing HLA-G1 molecules in pregnancy: decidua-associated natural killer cells express LIR-1 and CD94/NKG2A and acquire p49, an HLA-G1-specific receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.30103.X

A human histocompatibility leukocyte antigen (HLA)-G-specific receptor expressed on all natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.30103.X

Identification of a thymic epithelial cell subset sharing expression of the class Ib HLA-G molecule with fetal trophoblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.30103.X

Modulation of HLA-G antigens expression by human cytomegalovirus: specific induction in activated macrophages harboring human cytomegalovirus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.30103.X

HLA-G and NK receptor are expressed in psoriatic skin: a possible pathway for regulating infiltrating T cells?

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.30103.X

Implication of HLA-G molecule in heart-graft acceptance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.30103.X

Soluble HLA-G protein secreted by allo-specific CD4+ T cells suppresses the allo-proliferative response: a CD4+ T cell regulatory mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.30103.X

Porcine aortic endothelial cells transfected with HLA-G are partially protected from xenogeneic human NK cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.30103.X

HLA-G inhibits rolling adhesion of activated human NK cells on porcine endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.30103.X

The possible use of HLA-G1 and G3 in the inhibition of NK cell-mediated swine endothelial cell lysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.30103.X

The alpha1 domain of HLA-G1 and HLA-G2 inhibits cytotoxicity induced by natural killer cells: is HLA-G the public ligand for natural killer cell inhibitory receptors?

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.30103.X

The ILT2(LIR1) and CD94/NKG2A NK cell receptors respectively recognize HLA-G1 and HLA-E molecules co-expressed on target cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.30103.X

HLA-G truncated isoforms can substitute for HLA-G1 in fetal survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.30103.X

HLA-G1 co-expression boosts the HLA class I-mediated NK lysis inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.30103.X

Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.30103.X

HLA-G-mediated inhibition of antigen-specific cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.30103.X

HLA-G2, -G3, and -G4 isoforms expressed as nonmature cell surface glycoproteins inhibit NK and antigen-specific CTL cytolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.30103.X

HLA-G suppresses proliferation of CD4(+) T-lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.30103.X

Human leukocyte antigen-G expression after heart transplantation is associated with a reduced incidence of rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.30103.X

CD8+CD28- T suppressor cells and the induction of antigen-specific, antigen-presenting cell-mediated suppression of Th reactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.30103.X

Detection of T suppressor cells in patients with organ allografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.30103.X

Tolerization of dendritic cells by T(S) cells: the crucial role of inhibitory receptors ILT3 and ILT4

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.30103.X

Human leukocyte antigen G up-regulation in lung cancer associates with high-grade histology, human leukocyte antigen class I loss and interleukin-10 production

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.30103.X

Expression and regulation of HLA-G in human glioma cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.30103.X

A functional role of HLA-G expression in human gliomas: an alternative strategy of immune escape

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.30103.X

A soluble HLA-G protein that inhibits natural killer cell-mediated cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.30103.X

Re-examination of HLA-G polymorphism in African Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.30103.X

IL-10 selectively induces HLA-G expression in human trophoblasts and monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.30103.X

HLA-G inhibits the allogeneic proliferative response

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.30103.X

Maturation of antigen-presenting cells is compromised in HLA-G transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.30103.X

Role of HLA-G versus HLA-E on NK function: HLA-G is able to inhibit NK cytolysis by itself

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.30103.X

HLA-G has a concentration-dependent effect on the generation of an allo-CTL response

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.30103.X

Cutting edge: soluble HLA-G1 triggers CD95/CD95 ligand-mediated apoptosis in activated CD8+ cells by interacting with CD8

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.30103.X

Soluble human leukocyte antigen--G serum level is elevated in melanoma patients and is further increased by interferon-alpha immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.30103.X

Expression analysis of classic and non-classic HLA molecules before interferon alfa-2b treatment of melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.30103.X

Specific activation of the non-classical class I histocompatibility HLA-G antigen and expression of the ILT2 inhibitory receptor in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.30103.X

Aberrant expression of HLA-G antigen in interferon gamma-stimulated acute myelogenous leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.30103.X

HLA-G protein up-regulation in primary cutaneous lymphomas is associated with interleukin-10 expression in large cell T-cell lymphomas and indolent B-cell lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.30103.X

Alternative splicing of HLA-G transcripts yields proteins with primary structures resembling both class I and class II antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.30103.X

7 January 2021

The membrane-bound and soluble forms of HLA-G bind identical sets of endogenous peptides but differ with respect to TAP association

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.30103.X

7 January 2021

HLA-G expression protects porcine endothelial cells against natural killer cell-mediated xenogeneic cytotoxicity

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.30103.X

7 January 2021

Early events in cell-mediated recognition of vascularized xenografts: cooperative interactions between selected lymphocyte subsets and natural antibodies

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.30103.X

7 January 2021

HLA-G inhibits the transendothelial migration of human NK cells

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.30103.X

7 January 2021